Filing Flows › Comparisons › STIM vs BBNX
Neuronetics vs Beta Bionics: STIM and BBNX compared
Neuronetics is the larger company: $42.0M of revenue in its latest quarter (Q3 2026) against $35.5M for Beta Bionics (Q3 2026). Beta Bionics is growing faster (+30% against +12% a year earlier). Neuronetics is more profitable, with an operating margin of 1.3% against -74.9%.
Where the money goes: STIM and BBNX
Neuronetics (STIM) · Q3 2026
Neuronetics, Q3 2026: revenue $42.0M (+12% year over year), operating margin 1.3%, net loss $1.6M, operating cash flow $1.2M. The chart follows the revenue to costs, profit and cash.
Beta Bionics (BBNX) · Q3 2026
Beta Bionics, Q3 2026: revenue $35.5M (+30% year over year), operating margin -74.9%, net loss $24.4M, operating cash flow −$12.3M. The chart follows the revenue to costs, profit and cash.
| Neuronetics (STIM) | Beta Bionics (BBNX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $42.0M | $35.5M |
| Revenue growth, Y/Y | +12% | +30% |
| Operating margin | 1.3% | -74.9% |
| Net earnings | −$1.6M | −$24.4M |
| Net margin | -3.7% | -68.6% |
| Operating cash flow | $1.2M | −$12.3M |
| Free cash flow | $768K | — |
Where the revenue comes from
Neuronetics
- Service: $26.2M (62%)
- NeuroStar: $15.8M (38%)
Questions
Which is bigger, Neuronetics or Beta Bionics?
Neuronetics is the larger company: $42.0M of revenue in its latest quarter (Q3 2026) against $35.5M for Beta Bionics (Q3 2026).
Is Neuronetics or Beta Bionics growing faster?
Beta Bionics is growing faster (+30% against +12% a year earlier).
Which is more profitable, Neuronetics or Beta Bionics?
Neuronetics is more profitable, with an operating margin of 1.3% against -74.9%.
More: Neuronetics earnings · how Neuronetics makes money · Beta Bionics earnings · how Beta Bionics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Oct 27, 2026). Fiscal quarters can end on different dates. Not investment advice.